UTime Limited Partners with Dr. Ehud Baron to Pioneer AI-Driven Health Solutions
SHENZHEN, China, Aug. 19, 2024 /PRNewswire/ -- UTime Limited (NASDAQ: WTO) ("UTime" or the "Company") is pleased to announce a Memorandum of Understanding ("MOU") with XCardio, a Japanese company owned by Dr. Ehud Baron, a leader in medical technology innovation. This partnership focuses on the joint development of state-of-the-art continuous blood pressure monitoring devices, BPWatch, aimed at advancing cardiovascular...
CARsgen Announces Enrollment Completion in China GC/GEJ Pivotal Phase II Clinical Trial of the First-in-class Claudin18.2 CAR T (Satri-cel)
SHANGHAI, Aug. 19, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the completion of enrollment in the pivotal Phase II clinical trial of satricabtagene autoleucel ("satri-cel", R&D code: CT041, an autologous...
Health In Tech Partners with NovaNet and Tall Tree to Host Webinar on the Latest Strategies for Personalizing Client Health Coverage
The panel of experts will present the Zoom webinar to Tennessee Brokers as a Guide to Cost-Effective Health Coverage Options for their Clients STUART, Fla., Aug. 19, 2024 /PRNewswire/ -- Health In Tech, an industry-leading insurtech company that delivers disruptive innovation and reimagines self-funded health plans, today announced that the Company is going...
Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry
Europa Is One of the Largest Sports Nutrition Distributors With a Network of 10,000+ Gyms Across the United States Supports Prenetics' New Health and Wellness Brand IM8 with David Beckham as its Co-Founding Partner Projected Revenue of $100 Million+ in Consumer Segment for FY2025 CHARLOTTE, N.C., Aug. 19, 2024 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the...
China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025
HAIKOU, China, Aug. 19, 2024 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", or the "Company"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that through Hainan Helpson Medical and Biotechnology Co., Ltd. ("Helpson"), our wholly owned subsidiary, it expects to launch its Dry Eye Disease Therapeutic Device...
Ainex Unveils Advanced Endoscopy AI System at GIHEP & Singapore Hepatology Conference 2024
SINGAPORE, Aug. 19, 2024 /PRNewswire/ -- Ainex Corporation, a leading innovator in medical technology, has unveiled its advanced Endoscopy AI system, ENAD (Endoscopy as AI-powered Device), at the Combined GIHEP & Singapore Hepatology Conference 2024. This prestigious event, bringing together global experts in gastroenterology and hepatology, provided the perfect platform for Ainex to showcase ENAD, an innovative solution designed...
Genesis MedTech Announces the Sale of JC Medical, Inc to Edwards Lifesciences
SINGAPORE, Aug. 19, 2024 /PRNewswire/ -- Genesis MedTech has sold JC Medical, Inc. to Edwards Lifesciences, including the intellectual property and commercial rights of its J-Valve® System, a transcatheter aortic valve replacement for the treatment of severe aortic regurgitation. The transaction includes an upfront payment plus potential sales-based contingent milestones. Genesis MedTech has maintained the exclusive right to develop, manufacture and...
2024 World Life Science Conference Scheduled for October 19 in Hainan, China
BEIJING, Aug. 16, 2024 /PRNewswire/ -- On August 10, the third press conference for the 2024 World Life Science Conference (WLSC) was held in Beijing. Co-hosted by Hainan University and the China Union of Life Science Societies, the "One World, One Health"-themed event will take place from October 19 to 21 in Boao, Hainan. At the press conference, Yang...
De Motu Cordis (DMC) Applauds ARS Pharma’s FDA Approval of Neffy®, Expanding Patient Options to Needle-Free Epinephrine Delivery and Inspiring Confidence in Our Own Development Efforts
BRISBANE, Australia, Aug. 16, 2024 /PRNewswire/ -- De Motu Cordis (DMC) is pleased to acknowledge and enthusiastically commends the recent U.S. FDA approval of ARS Pharma's Neffy®, the first-ever needle-free intranasal epinephrine delivery device for the treatment of anaphylaxis. This groundbreaking approval, announced on August 9, represents a significant step forward in expanding emergency treatment options for patients at...
Sunway Medical Centre, Sunway City Awarded JCI Gold Seal of Approval
Malaysia's largest quaternary private hospital is the first in Malaysia to achieve three significant hospital-wide accreditations SUBANG JAYA, Malaysia , Aug. 16, 2024 /PRNewswire/ -- Sunway Medical Centre, Sunway City (SMC) has received the prestigious and globally recognised Joint Commission International (JCI) Accreditation, The Gold Seal of Approval under its Hospital Program. With this recently acquired accolade, SMC is the...
